11 Nov Fiona Young joins Sky Medical Technology
We recently welcomed Fiona Young as the new director for wound care therapy at Sky Medical Technology! Fiona has joined the team to lead the market adoption of the geko™ device for the healing of leg ulcers – a condition that affects millions of people globally every year.
Identifying the burden
Venous leg ulcers (VLUs):
- Make up more than 90 percent of all leg ulcer cases
- Impact up to three percent of the world’s adult population
- Cost the NHS almost £2 billion to treat every year
- Are slow to heal and difficult to treat with many patients experiencing recurrences within a year of healing
Standard of care recommends compression therapy, typically involving medically prescribed compression bandaging or stockings applied by a clinically trained wound specialist. However, there is no international census for gold standard leg ulcer care which likely contributes to the large number of patients (between 12 and 52 percent) struggling to adhere to treatment.
By enhancing standard of care with neuromuscular electrostimulation (NMES) via the geko™ device, wounds can heal faster, saving healthcare systems money and improving the lives of patients suffering with VLUs.
Appointing an expert
Fiona will play a vital role at Sky, helping drive market adoption of the geko™ device for leg ulcer healing. This comes at a pivotal time: the global wound care market is projected to experience significant growth over the next five years, driven by the increase of an ageing population and the rising use of technological advancements in innovative wound care products.
Fiona will use her 20-plus years’ experience to introduce and integrate new products into wound care pathways. From marketing and sales leadership roles at Flen Health, Crawford Healthcare and Lohmann & Rauscher, Fiona is equipped with the skills to help us grow in a market that is in genuine need of innovation.
Commenting on her appointment, Fiona shared: “I am excited to be joining Sky at this important time in the company’s development. Sky has an exceptionally dynamic technology platform with multiple large market opportunities – wound care therapy being among the largest of these. I am delighted to be working with the team and to lead a Partner-With-Us partner’ programme that will help drive geko™ device adoption. The market is ripe for the introduction of the clinically proven geko™ device, an innovation able to improve the lives of millions of patients living with chronic wounds.”
Read the full news story here.